Log in to save to my catalogue

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6326953

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Patients with newly diagnosed multiple myeloma (NDMM) with high-risk disease are in need of new treatment strategies to improve the outcomes. Multiple clinical, cytogenetic, or gene expression features have been used to identify high-risk patients, each of which has significant weaknesses. Inclusion of molecular features into risk stratification co...

Alternative Titles

Full title

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6326953

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6326953

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/s41375-018-0196-8

How to access this item